NORCET-11 Prelims
Medium

Ivacaftor is prescribed for a child diagnosed with cystic fibrosis. Before initiating therapy with this medication, which baseline laboratory assessment is most essential for the nurse to verify?

Appeared in: NORCET-11 Prelims

Explanation

  • Ivacaftor can cause elevations in liver enzymes and hepatotoxicity.
  • Baseline liver function tests are required to detect pre-existing hepatic impairment.
  • Ongoing monitoring of LFTs is recommended during therapy for early detection of adverse effects.

Why Other Options Were Wrong

  • Option A: Serum lipase and amylase assess pancreatic function, not directly affected by Ivacaftor.
  • Option C: CBC is not specifically required before Ivacaftor as hematologic toxicity is not a known risk.
  • Option D: Serum creatinine and BUN assess renal function; Ivacaftor is not nephrotoxic.

Related Visual

Ivacaftor initiation in cystic fibrosis: Baseline assessment steps, highlighting liver function tests as the critical safety check before starting therapy.
Clinical Relevance
  • Nursing practice connection: Safe nursing care depends on performing Baseline laboratory monitoring before starting Ivacaftor in cystic fibrosis in the correct sequence, documenting the action clearly, and monitoring for the expected response.
  • Nurses must verify baseline LFTs before starting Ivacaftor to prevent serious hepatic complications.
  • Early detection of liver dysfunction allows for prompt intervention, dose adjustment, or discontinuation if needed.
  • What if? If a child has elevated baseline LFTs, Ivacaftor may be delayed or not started, and further hepatic evaluation is warranted.
How to Approach the Question
  • Identify the drug and its major side effects or monitoring requirements.
  • Focus on the most serious or common adverse effect associated with the medication.
  • Eliminate options that do not relate to the drug's known toxicity profile.
  • Choose the laboratory test that directly addresses the main safety concern for the drug.
Concept Tested & Keywords
  • Concept Tested: Baseline laboratory monitoring before starting Ivacaftor in cystic fibrosis
  • Stem keywords: Ivacaftor, cystic fibrosis, child, baseline laboratory assessment
  • Lead-in keywords: most essential, verify
  • Clinical cues: Ivacaftor can cause liver enzyme elevation

Question ID

QHjVrNenlluU0165_OcAzF

Reference Book

E6 Pharmacology Nursing Lilley 11e Part 3 p. 31-33

Practise the full NORCET-11 Prelims

Attempt every question from this paper in a timed mock, then review the full solution for each one.